Vosevi Umoja wa Ulaya - Kiaisilandi - EMA (European Medicines Agency)

vosevi

gilead sciences ireland uc - sofosbuvir, velpatasvir, voxilaprevi - lifrarbólga c, langvinn - veirueyðandi lyf til almennrar notkunar - vosevi is indicated for the treatment of chronic hepatitis c virus (hcv) infection in patients aged 12 years and older and weighing at least 30 kg. (sjá kafla 4. 2, 4. 4 og 5.

Epclusa Umoja wa Ulaya - Kiaisilandi - EMA (European Medicines Agency)

epclusa

gilead sciences ireland uc - sofosbuvir, velpatasvir - lifrarbólga c, langvinn - veirueyðandi lyf til almennrar notkunar - epclusa is indicated for the treatment of chronic hepatitis c virus (hcv) infection in patients 3 years of age and older (see sections 4. 2, 4. 4 og 5.

Harvoni Umoja wa Ulaya - Kiaisilandi - EMA (European Medicines Agency)

harvoni

gilead sciences ireland uc - ledipasvir, sofosbuvir - lifrarbólga c, langvinn - veirueyðandi lyf til almennrar notkunar - harvoni is indicated for the treatment of chronic hepatitis c (chc) in adult and paediatric patients aged 3 years and above (see sections 4. 2, 4. 4 og 5. fyrir lifrarbólgu c veira (hcv) arfgerð-sérstakur starfsemi sjá kafla 4. 4 og 5.

Escitalopram Bluefish Filmuhúðuð tafla 5 mg Aislandi - Kiaisilandi - LYFJASTOFNUN (Icelandic Medicines Agency)

escitalopram bluefish filmuhúðuð tafla 5 mg

bluefish pharmaceuticals ab - escitalopramum oxalat - filmuhúðuð tafla - 5 mg